Corrigendum to "Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells"
Copyright © 2022 Hai-Bo Xing et al..
[This corrects the article DOI: 10.1155/2018/3195025.].
| Errataetall: |
ErratumFor: Biomed Res Int. 2018 Mar 6;2018:3195025. - PMID 29693005 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2022 |
|---|---|
| Enthalten in: |
BioMed research international - 2022(2022) vom: 30., Seite 9767389 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xing, Hai-Bo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 25.10.2022 published: Electronic-eCollection ErratumFor: Biomed Res Int. 2018 Mar 6;2018:3195025. - PMID 29693005 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1155/2022/9767389 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347924913 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347924913 | ||
| 003 | DE-627 | ||
| 005 | 20231226035001.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1155/2022/9767389 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1159.xml |
| 035 | |a (DE-627)NLM347924913 | ||
| 035 | |a (NLM)36277885 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Xing, Hai-Bo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells" |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.10.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumFor: Biomed Res Int. 2018 Mar 6;2018:3195025. - PMID 29693005 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2022 Hai-Bo Xing et al. | ||
| 520 | |a [This corrects the article DOI: 10.1155/2018/3195025.] | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Tong, Meng-Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Hong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhai, Chong-Ya |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Chang-Xin |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Da |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BioMed research international |d 2013 |g 2022(2022) vom: 30., Seite 9767389 |w (DE-627)NLM225739569 |x 2314-6141 |7 nnns |
| 773 | 1 | 8 | |g volume:2022 |g year:2022 |g day:30 |g pages:9767389 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1155/2022/9767389 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2022 |j 2022 |b 30 |h 9767389 | ||